Ervin Nika

发表

High nuclear level of Vav1 is a positive prognostic factor in early invasive breast tumors: a role in modulating genes related to the efficiency of metastatic process

M. Mottolese, S. Capitani, C. Rossi, 2014, Oncotarget.

hnRNP K in PU.1-containing complexes recruited at the CD11b promoter: a distinct role in modulating granulocytic and monocytic differentiation of AML-derived cells.

S. Capitani, R. Piva, V. Bertagnolo, 2014, The Biochemical journal.

Vav1 is ectopically expressed in breast tumors in which reduces the efficiency of the metastatic process

S. Capitani, M. Marchisio, V. Bertagnolo, 2014 .

In triple negative breast tumor cells, PLC-β2 promotes the conversion of CD133high to CD133low phenotype and reduces the CD133-related invasiveness

S. Capitani, V. Bertagnolo, M. Piazzi, 2013, Molecular Cancer.

A network including PU.1, Vav1 and miR-142-3p sustains ATRA-induced differentiation of acute promyelocytic leukemia cells - a short report

S. Capitani, R. Piva, V. Bertagnolo, 2016, Cellular Oncology.

Vav1 in differentiation of tumoral promyelocytes.

S. Capitani, V. Bertagnolo, Silvia Grassilli, 2012, Cellular signalling.

Nuclear proteome analysis reveals a role of Vav1 in modulating RNA processing during maturation of tumoral promyelocytes.

S. Capitani, R. Piva, V. Bertagnolo, 2011, Journal of proteomics.

Vav1 is necessary for PU.1 mediated upmodulation of miR‐29b in acute myeloid leukaemia‐derived cells

P. Pinton, S. Patergnani, S. Capitani, 2018, Journal of cellular and molecular medicine.

Vav1 is a crucial molecule in monocytic/macrophagic differentiation of myeloid leukemia-derived cells

P. Pinton, S. Capitani, V. Bertagnolo, 2011, Cell and Tissue Research.

Vav1 is a crucial molecule in monocytic/macrophagic differentiation of myeloid leukemia cells

P. Pinton, S. Capitani, V. Bertagnolo, 2010 .